Cite

HARVARD Citation

    Navid, F. et al. (2016). Feasibility of Pegylated Interferon in Children and Young Adults With Resected High‐Risk Melanoma. Pediatric blood & cancer. 63 (7), pp. 1207-1213. [Online]. 
  
Back to record